RKD Agri (511169)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Trailing sales growth of 5.13% shows some revenue momentum, though from a very small base and contradicted by the latest zero-sales quarter.
• Book value per share is positive at ₹0.77, so the asset base has not been completely eroded.
• Market capitalisation of ₹40 Cr is small enough that a modest absolute improvement in operations could move per-share metrics meaningfully.
• Current price of ₹6.81 is above the 52-week low of ₹3.85, showing the market is not pricing the stock purely for liquidation.

Concerns

• Latest quarter shows sales of ₹0 Cr and net profit of -₹0 Cr, leaving no fundamental earnings engine.
• ROE of -11.11% and ROCE of -2.22% indicate shareholder capital is being destroyed, while P/B of 8.84 means investors are paying 8.8 times book for that negative return.
• Piotroski F-Score of 3/9 reflects weak financial health and a high likelihood of continued stress.
• Zero dividend yield gives shareholders no income while waiting for any possible recovery.

AI Analysis

Let me begin with the obvious: I can only judge this business from the numbers before me, and those numbers do not support an investment. I look for a business I can understand, a durable moat, and a management that earns high returns on capital. RKD Agri, in other agricultural products, is a micro-cap with a market capitalisation of just ₹40 Cr. The latest quarter shows sales of ₹0 Cr and a net profit of -₹0 Cr. There is no profitable locomotive pulling this train. The P/E ratio of 0.00 is not a bargain signal; it means there are no earnings to underwrite. Without earnings, I am asked to pay ₹6.81 per share, or 8.84 times a book value of ₹0.77, for a company whose return on equity is -11.11% and return on capital employed is -2.22%. That is value destruction. As Ben Graham said, 'The investor's chief problem—and even his worst enemy—is likely to be himself.' I must not mistake a falling knife or a hopeful microcap for an opportunity. The 5.13% sales growth is faint praise when the latest quarter has zero sales. A Piotroski F-Score of 3 out of 9 reinforces my worry: weak profitability, weak financial strength, and weak operating efficiency. There is no dividend yield, so I receive no income while waiting. Is there a moat? I see none. Is there a margin of safety? Paying 8.8 times book for a negative-return business is the opposite. This could be a cyclical agricultural play or a turnaround someday, but I need evidence: a full quarter of real revenue, positive net profit, improving ROE and ROCE, and a clean balance sheet. Until then, this remains a speculative stock, not an investment. I would rather wait and miss a move than buy hope at 8.84 times book.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer